These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Ito BR; Roth DM; Engler RL Circ Res; 1990 Mar; 66(3):596-607. PubMed ID: 2137727 [TBL] [Abstract][Full Text] [Related]
3. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Bache RJ; Dai XZ Cardiovasc Res; 1992 Apr; 26(4):351-6. PubMed ID: 1638566 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Nichols WW; Mehta JL; Thompson L; Donnelly WH Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs. Nichols WW; Nicolini FA; Yang B; Robbins WC; Katopodis J; Chen L; Saldeen TG; Mehta JL J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555 [TBL] [Abstract][Full Text] [Related]
6. Role of endogenous prostacyclin in myocardial blood flow regulation distal to a severe coronary stenosis. Ruocco NA; Most AS; Sasken H; Steiner M; Gewirtz H Cardiovasc Res; 1988 Jul; 22(7):511-9. PubMed ID: 3075513 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog. Kopia GA; Valocik RE; Torphy TJ; Cieslinksi LB; Sarau HM; Foley JJ; Wasserman MA J Pharmacol Exp Ther; 1987 Apr; 241(1):174-80. PubMed ID: 2437287 [TBL] [Abstract][Full Text] [Related]
9. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction. Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270 [TBL] [Abstract][Full Text] [Related]
10. Involvement of leucocytes and leukotrienes in ischaemic dysfunction of the coronary microcirculation. Goldstein RE Eur Heart J; 1990 Apr; 11 Suppl B():16-26. PubMed ID: 2163844 [TBL] [Abstract][Full Text] [Related]
11. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4. Ezra D; Boyd LM; Goldstein RE; Feuerstein G J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457 [TBL] [Abstract][Full Text] [Related]
12. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo. Bove AA; Safford RE; Brum JM; Sufan Q; Dewey JD Prostaglandins; 1986 Nov; 32(5):665-77. PubMed ID: 3823487 [TBL] [Abstract][Full Text] [Related]
13. Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. Ezra D; Boyd LM; Feuerstein G; Goldstein RE Am J Cardiol; 1983 May; 51(8):1451-4. PubMed ID: 6303103 [TBL] [Abstract][Full Text] [Related]
14. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028 [TBL] [Abstract][Full Text] [Related]
15. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation. Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096 [TBL] [Abstract][Full Text] [Related]
16. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T; Iwai T; Haruta K; Takeda K Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999 [TBL] [Abstract][Full Text] [Related]
17. Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions. Grover GJ; Hedberg A; Ogletree ML Pharmacology; 1990; 41(1):1-15. PubMed ID: 2122481 [TBL] [Abstract][Full Text] [Related]